• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中一种外周多巴胺能标志物的失效

Failure of a peripheral dopaminergic marker in Parkinson's disease.

作者信息

Maloteaux J M, Laterre C E, Hens L, Laduron P M

出版信息

J Neurol Neurosurg Psychiatry. 1983 Dec;46(12):1146-8. doi: 10.1136/jnnp.46.12.1146.

DOI:10.1136/jnnp.46.12.1146
PMID:6663315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC491783/
Abstract

[3H]-spiperone binding on human lymphocytes did not reveal the occurrence of dopamine receptors. However, lower values were observed in Parkinsonism and the displaceable binding was increased after levodopa treatment although this was not specific only for levodopa and, furthermore, was not correlated with the clinical symptomatology. This non-specific binding in lymphocytes corresponds to trapping, presumably in lysosomes and thus does not reflect the dopaminergic receptors state in Parkinson's disease.

摘要

[3H]-司哌罗宁与人淋巴细胞的结合未显示多巴胺受体的存在。然而,在帕金森病患者中观察到较低的值,左旋多巴治疗后可置换结合增加,尽管这并非左旋多巴所特有,此外,也与临床症状无关。淋巴细胞中的这种非特异性结合对应于(药物)捕获,推测是在溶酶体中,因此不能反映帕金森病中多巴胺能受体的状态。

相似文献

1
Failure of a peripheral dopaminergic marker in Parkinson's disease.帕金森病中一种外周多巴胺能标志物的失效
J Neurol Neurosurg Psychiatry. 1983 Dec;46(12):1146-8. doi: 10.1136/jnnp.46.12.1146.
2
Parkinson's disease as a model for changes in dopamine receptor dynamics with aging.帕金森病作为多巴胺受体动力学随衰老变化的模型。
Gerontology. 1982;28 Suppl 1:35-52. doi: 10.1159/000212572.
3
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?帕金森病中的认知障碍是否由非多巴胺能损伤引起?
J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):201-6. doi: 10.1136/jnnp.52.2.201.
4
Cholinergic and dopaminergic mechanisms in Parkinson's disease after long term levodopa administration.
Lancet. 1982 Sep 25;2(8300):709-10. doi: 10.1016/s0140-6736(82)90728-0.
5
[Dopaminergic receptors on lymphocytes in idiopathic Parkinson's disease (author's transl)].特发性帕金森病淋巴细胞上的多巴胺能受体(作者译)
Rev Neurol (Paris). 1981;137(2):89-96.
6
[3H]spiperone binding to lymphocyte in extrapyramidal disease and in aging.锥体外系疾病及衰老状态下[3H]司哌隆与淋巴细胞的结合
Brain Behav Immun. 1987 Sep;1(3):197-203. doi: 10.1016/0889-1591(87)90022-5.
7
[On-off phenomena in Parkinson's disease. Continuous dopaminergic stimulation].[帕金森病的开关现象。持续多巴胺能刺激]
Clin Ter. 1987 Jul 31;122(2):83-8.
8
Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease.左旋多巴持续治疗对晚期帕金森病中枢多巴胺能机制的影响
Ann Neurol. 1990 Jan;27(1):18-23. doi: 10.1002/ana.410270105.
9
Pharmacotherapy of Parkinson's disease.帕金森病的药物治疗
Am J Hosp Pharm. 1977 May;34(5):531-8.
10
Receptor basis for dopaminergic supersensitivity in Parkinson's disease.帕金森病中多巴胺能超敏反应的受体基础。
Nature. 1978 May 4;273(5657):59-61. doi: 10.1038/273059a0.

引用本文的文献

1
The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.外周血淋巴细胞中的多巴胺能系统:从生理学到药理学,以及在神经精神疾病中的潜在应用。
Curr Neuropharmacol. 2011 Jun;9(2):278-88. doi: 10.2174/157015911795596612.

本文引用的文献

1
Decrease in lymphocyte [3H]spiroperidol binding sites in Parkinsonism.帕金森病中淋巴细胞[3H]螺哌啶结合位点的减少。
Life Sci. 1980 Oct 27;27(17):1587-91. doi: 10.1016/0024-3205(80)90568-8.
2
[Dopaminergic receptors on lymphocytes in idiopathic Parkinson's disease (author's transl)].特发性帕金森病淋巴细胞上的多巴胺能受体(作者译)
Rev Neurol (Paris). 1981;137(2):89-96.
3
Absence of dopamine and muscarinic receptors on human lymphocytes.人类淋巴细胞上不存在多巴胺和毒蕈碱受体。
Arch Int Pharmacodyn Ther. 1982 Jul;258(1):174-6.
4
Are dopamine receptors present on human lymphocytes?人类淋巴细胞上存在多巴胺受体吗?
J Pharm Pharmacol. 1982 Oct;34(10):658-63. doi: 10.1111/j.2042-7158.1982.tb04696.x.
5
Demonstration of vascular dopamine receptors in membranes from rabbit renal artery using 3H-spiroperidol binding.利用³H-螺哌啶醇结合法对兔肾动脉膜中血管多巴胺受体的检测。
Experientia. 1981 Oct 15;37(10):1099-101. doi: 10.1007/BF02085035.
6
The response of lysosomes in cultured neurons to chlorpromazine.培养神经元中溶酶体对氯丙嗪的反应。
J Neuropathol Exp Neurol. 1970 Jul;29(3):337-53. doi: 10.1097/00005072-197007000-00001.
7
Commentary. Lysosomotropic agents.述评。溶酶体亲和剂。
Biochem Pharmacol. 1974 Sep 15;23(18):2495-531. doi: 10.1016/0006-2952(74)90174-9.
8
Brain receptors for antipsychotic drugs and dopamine: direct binding assays.抗精神病药物与多巴胺的脑受体:直接结合测定
Proc Natl Acad Sci U S A. 1975 Nov;72(11):4376-80. doi: 10.1073/pnas.72.11.4376.
9
Receptor basis for dopaminergic supersensitivity in Parkinson's disease.帕金森病中多巴胺能超敏反应的受体基础。
Nature. 1978 May 4;273(5657):59-61. doi: 10.1038/273059a0.
10
Dopamine receptors in bovine retina : characterization of the 3H-spiroperidol binding and its use for screening dopamine receptor affinity of drugs.
Life Sci. 1979 Nov 5;25(19):1675-86. doi: 10.1016/0024-3205(79)90409-0.